• ISRIB (trans-isomer) in Memory and ER Stress

  2026-08-15

  ISRIB (trans-isomer) links molecular ISR control with practical studies of inflammation-associated forgetting, ER stress, and apoptosis. This workflow-focused guide shows how to use the compound as a PERK inhibitor and eIF2B-pathway modulator while separating memory rescue from nonspecific sickness or toxicity.

• Nelfinavir Mesylate: HIV-1 Protease Inhibition

  2026-08-14

  Nelfinavir Mesylate is an orally bioavailable HIV-1 protease inhibitor with nanomolar antiviral activity in cell-based models. Its established virology mechanism and emerging DDI2-related ferroptosis findings support carefully separated applications in HIV infection research and cell-death studies.

• Site-Specific PEGylation Blocks IL-11 in Lung Fibrosis

  2026-08-14

  The reference study engineered receptor-biased interleukin-11 by introducing a site-specific cysteine and PEGylating the GP130-binding interface, while largely preserving IL-11Rα recognition. In bleomycin-challenged mice, the optimized PEGylated analogs reduced extracellular-matrix deposition and preserved alveolar structure, supporting a targeted strategy for modulating profibrotic cytokine signaling.

• MK-0812: A Translational Lens on MASH Inflammation

  2026-08-13

  A thought-leadership guide to using MK-0812 as a selective CCR2 perturbation tool in MASH research, connecting monocyte trafficking biology with the intestinal TM6SF2–gut–liver axis and practical preclinical assay design.

• BCECF-AM for Intracellular pH Measurement

  2026-08-13

  BCECF-AM is a cell-permeable ratiometric fluorescent probe for pH that connects cytosolic acid–base changes with plant protein secretion research. This guide explains its chemistry, assay design, calibration logic, and the limits of interpreting cytosolic pH as a trafficking readout.

• DIDS: Chloride Transport Workflows for Cell Fate

  2026-08-12

  DIDS is an adaptable anion transport inhibitor for interrogating chloride-channel biology, cell-death escape, vascular reactivity, TRPV1 signaling, and hyperthermia responses. This workflow-focused guide emphasizes formulation control, orthogonal assays, and safeguards against mistaking broad pharmacology for target specificity.

• Cefiderocol Against Resistant European Non-Fermenters

  2026-08-12

  This European surveillance study directly compared cefiderocol with recent β-lactam/β-lactamase inhibitor combinations against 1,451 clinical Pseudomonas aeruginosa and Acinetobacter spp. isolates, including meropenem-resistant organisms. Cefiderocol retained high in vitro activity across most resistant subsets, while genomic analysis linked cefiderocol resistance mainly to siderophore-uptake pathway alterations, supporting parallel susceptibility testing rather than reliance on resistance to other β-lactams.

• TPCA-1: Reliable IKK-2 Inhibition in Cell Assays

  2026-08-11

  TPCA-1 (SKU A4602) is a selective IKK-2 inhibitor for mechanistic studies of NF-κB signaling, inflammatory cytokine release, and assay-linked changes in cell viability. This scenario-based guide explains how to control solvent effects, select informative concentration ranges, distinguish pathway inhibition from cell death, and evaluate product reliability.

• 3X (DYKDDDDK) Peptide Workflow Guide

  2026-08-11

  The 3X FLAG peptide combines a compact, hydrophilic epitope with strong anti-FLAG recognition for purification, detection, and structural biology workflows. This guide shows how to use it as a competitive elution reagent and assay-control tool while preserving functional readouts for recombinant proteins such as FANCJ.

• PreScission Protease for Condensate-Ready Proteins

  2026-08-10

  PreScission Protease enables sequence-specific, low-temperature removal of affinity tags while helping preserve sensitive recombinant proteins. This workflow guide connects precise tag cleavage with Drosophila Keap1 condensate assays, offering practical setup, optimization, and troubleshooting guidance.

• ATRX Loss and RTK Inhibitor Sensitivity in Glioma

  2026-08-09

  The reference study identifies ATRX deficiency as a potential determinant of sensitivity to receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its drug-screening and temozolomide-combination results support incorporating ATRX status into therapeutic studies and clinical-trial analyses, while leaving the precise molecular basis and clinical applicability for further investigation.

• Danazol: Reading HPG-Axis Models Correctly

  2026-08-08

  Danazol is more than an endocrine perturbant: it is a tool for separating androgen receptor signaling, steroidogenesis, and hypothalamic feedback in preclinical assays. This article interprets the 2025 rat study on herbal extract protection and translates its findings into better experimental decisions.

• Dacarbazine: Practical Cancer Assay Workflows

  2026-08-07

  Build more informative Dacarbazine response assays by separating growth inhibition from cell killing. This workflow covers fresh-solution handling, time-resolved viability measurements, model selection, combination screening, and troubleshooting for melanoma, lymphoma, and sarcoma research.

• PtrbZIP12 Phosphorylation Enhances Poplar Drought Tolerance

  2026-08-07

  This study demonstrates that the basic leucine zipper transcription factor PtrbZIP12 directly targets and activates PtrDHN and PtrPOD genes to enhance drought resistance in Populus trichocarpa. Notably, phosphorylation of PtrbZIP12 is a key modulator of this regulatory effect, highlighting the importance of post-translational modification in plant stress adaptation.

• Live-Dead Cell Staining Kit: Advanced Quantification in Diab

  2026-08-06

  Explore how the Live-Dead Cell Staining Kit delivers superior accuracy in cell viability assays, uniquely supporting advanced research in diabetic wound healing and redox biology. This in-depth guide integrates mechanistic insights with practical protocol strategies.

15703 records 1/1047 page Next 12345 下5页 Last page